Table 2 Demographic, clinical, and laboratory characteristics of 32 patients with persistent antiphospholipid antibody (aPL) profiles
Triple aPL Positive | LA Positive with/without aCL or aβ2GPI | LA Negative with aCL and/or aβ2GPI | |
|---|---|---|---|
(n:9) | (n:12) | (n:11) | |
aCL/aβ2GPI Level | |||
aCL/aβ2GPI IgG/M 20-39U | 1 (11%) | 3 (25%) | 7 (64%) |
aCL/aβ2GPI IgG/M ≥ 40U | 8 (89%) | 2 (17%) | 4 (36%) |
Demographics | |||
Mean Age at Presentation | 13.2 ± 4.65 | 14.7 ± 2.57 | 13.8 ± 4.95 |
Female | 7 (78%) | 11 (92%) | 10 (91%) |
White | 5 (56%) | 7 (58%) | 6 (55%) |
Black | 2 (22%) | - | 1 (9%) |
Hispanic | 1 (11%) | 3 (25%) | 2 (18%) |
Asian | 1 (11%) | 1 (8%) | 1 (9%) |
Lupus Classification | 5 (56%) | 7 (58%) | 5 (45%) |
Thrombosis | 5 (56%) | 3 (25%) | 1 (9%)* |
Venous | 4 | - | 1 |
Arterial | - | - | - |
Both Venous and Arterial | - | 1 | - |
Microvascular | 1 | 2 | - |
Non-thrombotic aPL Manifestations$ | 5 (56%) | 9 (75%) | 1 (9%)** |
Thrombocytopenia# | 1 | 4 | - |
Autoimmune Hemolytic Anemia | 2 | 2 | 1 |
Cardiac Valve Disease | - | 1 | - |
Livedo Reticularis/Racemosa | 1 | 1 | - |
Migraines*** | 3 | 2 | - |
Chorea *** | 1 | - | - |